Weight loss drugs are bringing down the country's obesity rate
6 months ago
- #healthcare access
- #weight loss drugs
- #obesity
- Obesity rate in U.S. adults dropped to 37% from 39.9% three years ago.
- Use of weight loss drugs like semaglutide and tirzepatide more than doubled in the past year and a half.
- GLP-1 agonists, approved in 2021, are considered a breakthrough in obesity treatment.
- Obesity rates declined more among those aged 40-64, correlating with higher GLP-1 medication use.
- Access to GLP-1 drugs is limited, with many insurers stopping coverage, making them expensive for patients.